Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.
Traded Jan 9, 2026 · Filed Jan 12, 2026
AAR's Senior Vice President-CCO sold $5.7K of AAR shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$5,723
Shares × reported transaction price
3 days after results of Jan 6, 2026, 74 days before results of Mar 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.1% | −2.3% | +8.4% |
| 30 days | +15.9% | −1.8% | +17.7% |
| 90 days | +26.7% | −1.1% | +27.8% |
| 180 days | +34.0% | +8.0% | +26.0% |
Past results only. Not a forecast.
Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.
Traded Feb 4 · filed the same dayNot under a reported trading plan
The CFO of AAR sold $1.17M of AAR shares. The filing does not indicate a pre-arranged trading plan.
Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.